Kiniksa Pharmaceuticals
Price & Volume
Stats
See more52W Range | $35.20-$82.94 |
Market Cap | $6B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $840.8M |
Revenue Growth (YoY) | 55.4% |
Gross Profit (12 Mos) | $458.2M |
Diluted EPS | $0.99 |
News
See moreYahoo Finance • 2 months ago
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
Yahoo Finance • 3 months ago
Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution
Yahoo Finance • 4 months ago
Kymera Appoints Felix Baker As Board Chairman, Succeeds Bruce Booth
Yahoo Finance • 5 months ago
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
About
CEO | Mr. Sanjiv K. Patel |
CFO | Mr. Mark A. Ragosa C.F.A. |
Address | 105 Piccadilly, London, United Kingdom, W1J 7NJ |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 366 |